Further detail on the adverse events was not provided, but were all from patients who received preservative free methylprednisolone acetate (80 mg/mL) by injection, according to the FDA.
The FDA has recommended providers not administer any products from Main Street until further guidance is provided.
More Articles on Compounding Pharmacy Contamination:
FDA Warns Drugs From Florida Compounding Shop May Be Contaminated
New Sterile Compounding Guidelines Released
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
